Depression
News, opinions and meeting coverage in psychiatry.
<ѻýҕl>APA Meeting Highlights Mental Health Biologyѻýҕl>
NEW YORK CITY -- The biological basis for normal and abnormal mental function is emerging as a dominant theme in psychiatry research, and the American Psychiatric Association annual meeting that starts here Saturday won't be an exception.
May 01, 2014
<ѻýҕl>Pot Smokers Who Quit Find It Harder to Functionѻýҕl>
The more severe a person's marijuana withdrawal symptoms when they quit using the drug, the bigger the effect on their functional ability and the more likely they were to start using again, results of an Australian study showed.
Sep 27, 2012
<ѻýҕl>Lab Notes: Red Wine Before Radiation and Red Clover for Hair Lossѻýҕl>
Red is the color of the day, as components of red wine and red clover lead this week's Lab Notes, but the blues get their turn in the spotlight, too, as depressed people outshine cheerier folks in some elements of decision making.
May 06, 2011
<ѻýҕl>FDA Panel: Keep ECT Devices as High Riskѻýҕl>
GAITHERSBURG, Md. -- The FDA should continue to regulate electroconvulsive therapy (ECT) machines as high-risk devices for treating depression and most other conditions for which ECT is typically used, members of the agency's Neurological Devices Advisory Committee agreed.
Jan 28, 2011
<ѻýҕl>Grief Following Death in the Family Ebbs in Six Months
ѻýҕl>
NEW HAVEN -- The negative emotions of grief -- yearning, depression, and anger -- following the death of a family member from natural causes usually peak within six months, according to a Yale bereavement study of 233 mourners
Feb 21, 2007
<ѻýҕl>FDA Warns on Mixing Antidepressants with Migraine Drugs
ѻýҕl>
ROCKVILLE, Md. -- Mixing common migraine drugs such as Imitrex (sumatriptan) with antidepressants like Prozac (fluoxetine) or Cymbalta (duloxetine) can trigger a life-threatening condition called serotonin-syndrome, the FDA has warned.
Jul 20, 2006
<ѻýҕl>FDA Approves First Antidepressant Transdermal Patchѻýҕl>
ROCKVILLE, Md. - The FDA has approved a once-a-day antidepressant patch that delivers a monoamine oxidase inhibitor. Called Emsam (selegiline), the patch can be used at its lowest dose without the dietary restrictions that accompany oral MAO inhibitors.
Mar 01, 2006
<ѻýҕl>St. John's Wort Better than SSRI for Moderate to Severe Depressionѻýҕl>
A study published in The British Medical Journal found that a herbal extract of St. John's wort was at least as effective as Paxil(R) (paroxetine) and had fewer side effects in patients with moderate to severe depression.
Feb 11, 2005
<ѻýҕl>Provigil (modafinil) Counteracts SSRI Side Effectsѻýҕl>
Provigil ® (modafinil) not only counteracted the excessive fatigue and somnolence experienced by some patients on selective serotonin reuptake inhibitors (SSRIs), but also improved mood and quality of life in this patient group, according to a preliminary study published in the Journal of Clinical Psychiatry.
Oct 23, 2004